Owkin raised €74M in a Series B round in Jun 2022. The company is based in Paris, France. Investors in the round: Bristol Myers Squibb. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
